Navigation Links
The Results From a Clinical Trial Led by the Montreal Heart Institute Demonstrate That Drug Reduces Inflammation in Patients With Serious Cardiovascular Disease
Date:11/10/2008

MONTREAL, Nov. 10 /PRNewswire/ -- Montreal Heart Institute Research Centre Director Dr. Jean-Claude Tardif presented yesterday results from a clinical trial demonstrating that VIA-2291, an investigational drug being developed by VIA Pharmaceuticals, Inc., significantly inhibited production of leukotrienes, proposed mediators of vascular inflammation, in patients with serious heart disease. VIA-2291 was well-tolerated with no serious adverse events attributed to the drug. The study was presented in a Special Session at the American Heart Association 2008 Scientific Sessions in New Orleans, Louisiana.

The study of VIA-2291 was designed to establish optimal dosing and safety data in patients with acute coronary syndromes (ACS), who recently had a heart attack or unstable angina. 191 patients were treated once daily for 12 weeks with one of three dose levels of VIA-2291 or placebo. A sub-study of patients continued for an additional 12 weeks of treatment.

Cardiologists have several therapies that help reduce heart disease risk factors, but none that specifically target inflammation, an underlying cause of atherosclerosis, which leads to major adverse cardiac events (MACE), including heart attack and stroke.

VIA-2291 is designed to be a selective and reversible inhibitor of 5-LO, a key enzyme in the biosynthesis of leukotrienes, that are important mediators of inflammation believed to be involved in the development and progression of atherosclerosis.

"VIA-2291 has the potential to be the first drug to specifically target one cardiovascular inflammatory pathway," said Dr. Jean-Claude Tardif, the VIA-2291 ACS trial's principal investigator, director of the Montreal Heart Institute Research Centre and professor of medicine at the Universite de Montreal. "These data support further clinical development of this drug, including larger outcome trials."

Study Results

The trial demonstrated a statistically significant, dose-depende
'/>"/>

SOURCE Montreal Heart Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Chindex International Inc. Reports Second Quarter FY 2009 Financial Results
2. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance
3. MGT Capital Investments Reports Third Quarter 2008 Financial Results and Provides Update on Recent Developments
4. China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results
5. Ellex Announces Six-Month Results on Retina Regeneration Therapy
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
7. InfoLogix to Report Third Quarter Financial Results on November 10, 2008
8. Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2009 Financial Results on Monday, November 10th, at 4:30 P.M. EST
9. China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates
10. Fraxel(R) Laser Systems Shown to Provide Superior Results Compared to Pseudo Fractional Laser Technologies
11. NutraCea Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... June 01, 2015 KC and Monica ... $88,000 of the best superfood products in ... floods in Texas. , "Monica and I are ... News in distributing Living Fuel Super Meals - SuperBerry®, ... millennial floods in Texas," KC Craichy said. "We have ...
(Date:6/1/2015)... June 01, 2015 Northridge dentist ... now offering patients a promotion on Invisalign for a ... Invisalign treatment is reduced to $3,700. Patients can find ... complimentary consultation and discuss the extent of correction they ... cannot be combined with any other offer. , ...
(Date:6/1/2015)... Norcross, GA. (PRWEB) June 01, 2015 ... Producer Online, which is a new cloud-based subscription service ... sensing and GIS software. , Both ERDAS IMAGINE ... online access through Producer Online, which offers a subscription ... , “Today’s organizations need to be able to quickly ...
(Date:6/1/2015)... 01, 2015 This is the final ... Conference: The Future of Local Food, June 11 - ... will assist cities in examining and developing solutions ... infrastructure. , Organized for the city of Riverside by ... broad lineup of speakers ranging from urban agriculture entrepreneurs, ...
(Date:6/1/2015)... Calif. (PRWEB) June 01, 2015 Kurbo ... program for children and teens, announced today it has ... coaching channels for kids and teens to eat smart and ... communicated with their coaches via text message and phone or ... supportive reminders through their in-app chat window. For paid users, ...
Breaking Medicine News(10 mins):Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:Northridge Dentists, Drs. Michel Elyson and Ramin Assili, are Now Offering a Limited Time Promotion on Invisalign 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3Health News:Limited Tickets Available for “GrowRIVERSIDE” Conference June 11 2Health News:Kurbo, First Mobile Weight Loss Program for Children and Teens, Enhances Coaching with New iOS In-App Chat and Messaging from Coaches 2
... (OSA) may improve their memory by using continuous positive ... majority of patients// with OSA, who were memory-impaired prior ... of optimal CPAP use. The study also showed that ... used CPAP for at least 6 hours a night ...
... Americans turn to in-home health care workers to take care ... law professor has found nobody is// taking care of the ... has found that most home health care workers are protected ... take for granted. ,"For the most part, those ...
... investigation report by some of Britain's leading scientists have ... improve human health and reduce deaths// from disease. But ... ,While speaking on the use of primates, ... that ‘In some cases primates are essential to answer ...
... publication in the Journal of Clinical Endocrinology and ... provided by The Hormone Foundation, the public education ... Lifestyle Accelerates Testosterone Decline ... but a new study confirms that many health ...
... early diagnosis of cancer, heart disease, diabetes, early detection. ... cancer//, heart disease and diabetes is being developed by ... on the project at Dublin City University. ... early telltale signs of these killer diseases. ...
... HIV/AIDS healthcare provider will soon be reaching out to ... to provide treatment and support//. ,The US-based AIDS ... and testing centres in Assam's main city of Guwahati, ... of Silchar. ,India's National AIDS Control ...
Cached Medicine News:Health News:Memory Improves After Sleep Apnea Therapy 2Health News:Law Professor Finds Home Health Care Workers Have Few Legal Protections 2Health News:Law Professor Finds Home Health Care Workers Have Few Legal Protections 3Health News:Britain Scientists Support the Use of Primates in Research 2Health News:Testosterone Decline in Men Linked to Lifestyle, Increases in Obese Girls 2Health News:US NGO to Counsel HIV/AIDS Patients in Assam 2
(Date:6/1/2015)... May 29, 2015 Research and Markets ... the "Global A Dialyzer Reprocessing Machine (A ... to their offering. The Global A ... Report 2014 is a professional and in-depth study ... reprocessing machine industry. The report provides a ...
(Date:6/1/2015)...  Boston Biomedical, an industry leader in the development ... (CSC) pathways, will present clinical data today on the ... at the 2015 American Society of Clinical Oncology (ASCO) ... Data presented at ASCO highlight the potential of ... leading to inhibition of the critical genes for maintaining ...
(Date:6/1/2015)... , June 1, 2015   OTC ... Open, Transparent and Connected financial marketplaces for 10,000 ... a San Diego -based biopharmaceutical ... on OTCQB®, America,s only public venture market for ... - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO "We,re ...
Breaking Medicine Technology:Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 2Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 4Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 5Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 6Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 7OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... DIEGO, Dec. 20, 2010 Optimer Pharmaceuticals, Inc. ... Gregory Papaz has joined Optimer as Senior Vice ... the preparations for the planned commercialization of fidaxomicin. ... of experience in the healthcare and pharmaceutical industry ...
... XI,AN, China, Dec. 20, 2010 /PRNewswire-Asia-FirstCall/ -- DK Sinopharma, Inc. (OTC ... was honored at a grand awards ceremony on December 8, 2010 ... Paying Credit Rating on September 30, 2010. "We ... third time in a row that the Company has been rated ...
Cached Medicine Technology:Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations 2Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations 3DK Sinopharma, Inc. is Honored as 'A-class Taxpayer' for the Third Time 2DK Sinopharma, Inc. is Honored as 'A-class Taxpayer' for the Third Time 3
Manufactured form the same soft siliconized PVC as all Portex® Blue Line® tracheostomy tubes....
... safety, the laryngectomy tube is ... mm ISO termination that can ... with or without the inner ... ,Portex® laryngectomy tubes are used ...
... When the all silicone cuff ... no distinguishable dimension to the ... shaft, yet it can be ... varied airway management needs. TTS™ ...
... are often indicated for tracheal problems ... malacia. Available in four adult sizes, ... cuffs. Greater flexibility in providing airway ... can be alternated, when appropriate, or ...
Medicine Products: